Company Overview and News


Add CDNA
to your dashboard

Headline News

Stocks To Watch: Automakers Rev Up For 2018

2017-12-31 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn on the e-mail alert on to receive this article in your inbox every Saturday morning. (629-3)

Here's Why You Should Steer Clear of LifePoint (LPNT) Stock

2017-12-12 zacks
LifePoint Health Inc.’s (LPNT - Free Report) guidance cut for third-quarter 2017 earnings and weak industry trends owing to softness in patient admission volumes have been dampening market sentiments, of late. (15-0)

The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

2017-12-07 zacks
Chicago, IL – Dec 7, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Aetna Inc. (AET - Free Report) , CareDx Inc. (CDNA - Free Report) , PRA Health Sciences, Inc. (PRAH - Free Report) and Diplomat Pharmacy, Inc. (165-0)

4 Attractive Stocks to Buy in an Evolving Healthcare Space

2017-12-06 zacks
The healthcare sector has been under the spotlight for quite some time for a host of reasons —regulatory uncertainty, increasing consumerism and consolidation being the most prominent. (148-0)

The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

2017-12-01 zacks
Chicago, IL – December 1, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include BioLife Solutions, Inc. (BLFS - Free Report) , SeaSpine Holdings Corp. (SPNE - Free Report) , Apollo Endosurgery, Inc. (APEN - Free Report) and CareDx, Inc (CDNA - Free Report) . (98-0)

4 Top-Ranked Growth Stocks in MedTech Under $20

2017-11-30 zacks
The Healthcare sector has been delivering impressive performance so far this year and the comparative performance of the Health Care Index (XLV) to other major indices says it all. This index has rallied 18.7% year to date in comparison with the S&P 500 Index’s gain of 17.3%. (59-0)

Reimbursement cuts on lab tests pressure US lab firm shares - Channel NewsAsia

2017-11-20 channelnewsasia
REUTERS: A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as US$3 billion over five years, but hurt margins of U.S. laboratory companies. (34-1)

Reimbursement cuts on lab tests pressure US lab firm shares

2017-11-20 reuters
(Reuters) - A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies. (34-2)

Teladoc Rides on Growing Demand for Telehealth Services

2017-11-15 zacks
Teladoc Inc. (TDOC - Free Report) , a premier telehealth services provider, is expanding its business in the booming telehealth services industry. Increased adoption of the company’s services has led to growth in memberships and visits. This in turn has been generating substantial revenues. The company’s revenues have increased at a CAGR of 80% from 2013-2016. The trend was maintained in the first nine months of 2017. (66-1)

CareDx's (CDNA) CEO Peter Maag on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Good day, ladies and gentlemen, and welcome to the CareDx Third Quarter 2017 Earnings Call. Today’s conference is being recorded. And at this time, I’d like to turn the floor over to David Clair, ICR, Investor Relations. Please go ahead. (2-0)

Low Waste Revenues to Hurt Stericycle's (SRCL) Q3 Earnings?

2017-11-06 zacks
Waste management firm Stericycle, Inc. (SRCL - Free Report) is scheduled to report third-quarter 2017 results after the closing bell on Nov 8. The company is likely to report lower revenues in Regulated Waste and Compliance Services segment that accounts for more than half of total revenues, due to stiff industry-wide competition. This is likely to result in lower earnings for the quarter. Top-Line Woes Stericycle operates in a highly-competitive market. (5-0)

Will Tinder & PMC Growth Aid Match Group (MTCH) Q3 Earnings?

2017-11-04 zacks
Match Group, Inc. (MTCH - Free Report) is set to report third-quarter 2017 earnings results on Nov 8. (13-0)

10 Cheap Stocks to Buy With Only $12 | InvestorPlace

2017-11-01 investorplace
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all offer impressive value for money and big upside potential. (84-1)

PAREXEL's Acquisition by Pamplona Approved by Shareholders

2017-09-27 zacks
PAREXEL International Corporation (PRXL - Free Report) is again in the news following the receipt of shareholders’ approval for the impending sell-off of the company to certain investment funds associated with Pamplona Capital Management. The transaction is expected to be completed by Sep 29 following which the company will turn into a privately-held organization (15-1)

CareDx Release: MolDX Sets AlloSure Reimbursement At 2017 AlloMap Level

2017-09-26 devicespace
BRISBANE, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, received notice that the Molecular Diagnostics Services (MolDX) Program developed by Palmetto GBA has set AlloSure reimbursement at $2,840.75, which is same reimbursement as AlloMap in 2017. (2-0)

CUSIP: 14167L103